Maheshwari H G, Silverman B L, Dupuis J, Baumann G
Center for Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611, USA.
J Clin Endocrinol Metab. 1998 Nov;83(11):4065-74. doi: 10.1210/jcem.83.11.5226.
We report, in detail, a new form of familial dwarfism, including its phenotypic features, hormonal profile, and molecular basis. Following a newspaper report of severe dwarfism in two villages in the province of Sindh, Pakistan, we organized an expedition to study its clinical, genetic, and molecular characteristics. We identified 18 dwarfs (15 male, 3 female), all members of a consanguineous kindred, ranging in age from newborn to 28 yr. Mean height was 7.2 SD below the norm, with mean adult heights of 130 cm for males and 113.5 cm for females. Body proportions and habitus were normal; but head circumference was 4.1 SD, and blood pressure approximately 3 SD below the norm. There was no dysmorphism, no microphallus, and no history of hypoglycemia. Serum GH did not respond to provocative stimuli (GHRH, L-dopa, or clonidine). Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 were low (5.2 +/- 2.0 ng/mL and 0.42 +/- 0.13 microg/mL, respectively; mean +/- SD) but rose normally with GH treatment. One affected, dwarfed couple had a son, demonstrating fertility in both sexes. Clinical and endocrinological evidence suggested isolated GH deficiency with a recessive inheritance pattern. The GH-N gene was found to be intact. Linkage analysis of microsatellite chromosomal markers near other candidate genes yielded a high LOD score (6.26) for the GHRH receptor (GHRH-R) locus. DNA sequencing revealed a nonsense mutation (Glu50-->Stop) in the extracellular domain of the GHRH-R. This mutation predicts a severely truncated GHRH-R; it is identical to that recently reported in four patients from two other families. Inheritance is autosomal recessive (chromosome 7p) with a high degree of penetrance. Relatives heterozygous for the mutation had moderately decreased IGF-I levels and slightly blunted GH responses to GHRH and L-dopa, but they showed only minimal or no height deficit. This syndrome represents the human homologue of the little (lit/lit) mouse and closely resembles its phenotype. It demonstrates the absolute requirement of GHRH signaling for pituitary GH secretion and postnatal growth in humans, and its relatively minor (but discernible) biological importance in extrapituitary sites. The syndrome is distinct from other forms of GH deficiency with respect to microcephaly, asymptomatic hypotension, and absence of features such as facial dysplasia, significant truncal obesity, microphallus, or hypoglycemia. Its discovery raises the possibility of milder mutations in the GHRH-R gene as potential causes for partial GH insufficiency and idiopathic short stature.
我们详细报告了一种新型家族性侏儒症,包括其表型特征、激素谱和分子基础。在巴基斯坦信德省两个村庄出现严重侏儒症的报纸报道之后,我们组织了一次考察,以研究其临床、遗传和分子特征。我们鉴定出18名侏儒(15名男性,3名女性),他们均为近亲家族成员,年龄从新生儿到28岁不等。平均身高比正常水平低7.2个标准差,成年男性平均身高为130厘米,成年女性平均身高为113.5厘米。身体比例和体型正常;但头围比正常水平低4.1个标准差,血压比正常水平低约3个标准差。没有畸形、小阴茎,也没有低血糖病史。血清生长激素(GH)对刺激物(生长激素释放激素(GHRH)、左旋多巴或可乐定)无反应。胰岛素样生长因子I(IGF-I)和IGF结合蛋白3水平较低(分别为5.2±2.0纳克/毫升和0.42±0.13微克/毫升;平均值±标准差),但经GH治疗后正常升高。一对患侏儒症的夫妇育有一个儿子,表明两性均有生育能力。临床和内分泌学证据提示为孤立性生长激素缺乏症,呈隐性遗传模式。发现生长激素 - N基因完整无损。对其他候选基因附近的微卫星染色体标记进行连锁分析,结果显示生长激素释放激素受体(GHRH - R)基因座的对数优势分数(LOD)很高(6.26)。DNA测序揭示在GHRH - R的细胞外结构域存在一个无义突变(Glu50→终止密码子)。该突变预测会产生一个严重截短的GHRH - R;这与最近在另外两个家族的4名患者中报道的突变相同。遗传方式为常染色体隐性遗传(染色体7p),外显率很高。该突变的杂合亲属的IGF - I水平中度降低,对GHRH和左旋多巴的生长激素反应略有减弱,但他们仅表现出轻微或无身高缺陷。这种综合征代表了小鼠“little(lit/lit)”的人类同源物,其表型与之极为相似。它证明了GHRH信号传导对于人类垂体生长激素分泌和出生后生长的绝对必要性,以及它在垂体外部位相对较小(但可察觉)的生物学重要性。该综合征在小头畸形、无症状性低血压以及不存在面部发育异常、明显的躯干肥胖、小阴茎或低血糖等特征方面,与其他形式的生长激素缺乏症不同。它的发现增加了GHRH - R基因中存在较温和突变作为部分生长激素不足和特发性身材矮小潜在病因的可能性。